# Certolizumab pegol

## Cimzia inj 200mg/1mL

##### 臨採

| Title              | Content                                                                                                                                                                                                                                                                                                                                                                                   |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| TAH Drug Code      | ICIM                                                                                                                                                                                                                                                                                                                                                                                      |
| Indications        | No Data                                                                                                                                                                                                                                                                                                                                                                                   |
| Dosing             | SC， Ankylosing spondylitis， non-radiographic axial spondyloarthritis， plaque psoriasis， psoriatic arthritis， rheumatoid arthritis 400 mg once and then repeat at weeks 2 and 4; maintenance， 200 mg every 2 weeks or 400 mg once every 4 weeks. Crohn's disease 400 mg (as 2 injections of 200 mg) once and then repeat at weeks 2 and 4; maintenance ， 400 mg once every 4 weeks. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                             |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                             |
| Contraindications  | No Data                                                                                                                                                                                                                                                                                                                                                                                   |
| Adverse Effects    | No Data                                                                                                                                                                                                                                                                                                                                                                                   |
| Pregnancy          | No (limited) human data – animal data suggest low risk                                                                                                                                                                                                                                                                                                                                    |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                             |

